<DOC>
	<DOCNO>NCT00030069</DOCNO>
	<brief_summary>This study determine response rate patient myelodysplastic syndrome treat calcitriol dexamethasone .</brief_summary>
	<brief_title>Calcitriol Dexamethasone Patients With Myelodysplastic Syndromes</brief_title>
	<detailed_description>Current therapeutic option myelodysplastic syndrome ( MDS ) limit , aside bone marrow transplantation , none proven superior supportive measure alone . Preclinical investigation indicate potential therapeutic role vitamin D treatment MDS . However , dose-limiting toxicity hypercalcemia , past clinical trial vitamin D force utilize low dos , promise inconsistent result . This study utilize dose schema dexamethasone ( Dex ) calcitriol ( active form vitamin D ) augment therapeutic index calcitriol , allow safe administration 5-10 time higher dose calcitriol previously use clinical trial MDS . Patients receive dexamethasone 4 time per week calcitriol 3 time per week . This schedule continue weekly patient study . The dose calcitriol increase maximum tolerate dose ( MTD ) determine . History physical examination , blood monitoring , urinary ultrasound , bone marrow aspiration biopsy use assess disease response .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Inclusion criterion : Histologically confirm refractory anemia ( RA ) , RA excess blast ( RAEB ) , RAEB transformation ( RAEBIT ) , ring sideroblast ( RARS ) Evidence cytopenia affect least 1 hematological cell lineage Adequate liver renal function ECOG 02 Expected survival least 12 week Exclusion criterion : Symptomatic coronary artery disease Uncontrolled diabetes mellitus Uncontrolled symptomatic glaucoma History dangerous reaction steroid therapy Chemotherapy hematopoietic growth factor therapy within past 8 week History nephrolithiasis Children Chronic myelomonocytic leukemia ( CMML )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Hematopoiesis</keyword>
	<keyword>Apoptosis</keyword>
	<keyword>Cell Differentiation</keyword>
	<keyword>Bone Marrow Cells</keyword>
</DOC>